Condition
Seasonal Malaria Chemoprevention
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06599593Not ApplicableActive Not Recruiting
Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition
NCT06182176Not ApplicableUnknown
Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control
NCT05354258Not ApplicableUnknown
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children
Showing all 3 trials